|
1
|
Jiang Y, Zhou X, Hu R and Dai A:
TGF-β1-induced SMAD2/3/4 activation promotes RELM-β transcription
to modulate the endothelium-mesenchymal transition in human
endothelial cells. Int J Biochem Cell Biol. 105:52–60. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jackson AO, Zhang J, Jiang Z and Yin K:
Endothelial-to-mesenchymal transition: A novel therapeutic target
for cardiovascular diseases. Trends Cardiovasc Med. 27:383–393.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sato Y and Nakanuma Y: Role of
endothelial-mesenchymal transition in idiopathic portal
hypertension. Histol Histopathol. 28:145–154. 2013.PubMed/NCBI
|
|
4
|
Kato T, Sekiguchi A, Sagara K, Tanabe H,
Takamura M, Kaneko S, Aizawa T, Fu LT and Yamashita T:
Endothelial-mesenchymal transition in human atrial fibrillation. J
Cardiol. 69:706–711. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kluz J, Kopeć W, Jakobsche-Policht U and
Adamiec R: Circulating endothelial cells, endothelial apoptosis and
soluble markers of endothelial dysfunction in patients with
systemic lupus erythematosus-related vasculitis. Int Angiol.
28:192–201. 2009.PubMed/NCBI
|
|
6
|
Rakic M, Persic V, Kehler T, Bastiancic
AL, Rosovic I, Laskarin G and Sotosek Tokmadzic V: Possible role of
circulating endothelial cells in patients after acute myocardial
infarction. Med Hypotheses. 117:42–46. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lombardo MF, Iacopino P, Cuzzola M,
Spiniello E, Garreffa C, Ferrelli F, Coppola A, Saccardi R,
Piaggesi A, Piro R, et al: Type 2 diabetes mellitus impairs the
maturation of endothelial progenitor cells and increases the number
of circulating endothelial cells in peripheral blood. Cytometry A.
81:856–864. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
O'Reilly M, Holmgren L, Shing Y, Chen C,
Rosenthal RA, Cao Y, Moses M, Lane WS, Sage EH and Folkman J:
Angiostatin: A circulating endothelial cell inhibitor that
suppresses angiogenesis and tumor growth. Cold Spring Harb Symp
Quant Biol. 59:471–482. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Beerepoot LV, Mehra N, Vermaat JS,
Zonnenberg BA, Gebbink MF and Voest EE: Increased levels of viable
circulating endothelial cells are an indicator of progressive
disease in cancer patients. Ann Oncol. 15:139–145. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Freestone B, LiP GH, Chong A, Nadar S, Lee
KW and Blann AD: Circulating endothelial cells in atrial
fibrillation with and without acute cardiovascular disease. Thromb
Haemost. 94:702–706. 2005.PubMed/NCBI
|
|
11
|
Agarwal S, Loder S, Cholok D, Peterson J,
Li J, Fireman D, Breuler C, Hsieh HS, Ranganathan K, Hwang C, et
al: Local and circulating endothelial cells undergo endothelial to
mesenchymal transition (EndMT) in response to musculoskeletal
injury. Sci Rep. 6:325142016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu JU, Dong F, Jeong J, Masuda T and Lobe
CG: Constitutively active Notch1 signaling promotes
endothelial-mesenchymal transition in a conditional transgenic
mouse model. Int J Mol Med. 34:669–676. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Z, Han Z, Tao J, Wang J, Liu X, Zhou
W, Xu Z, Zhao C, Wang Z, Tan R and Gu M: Role of
endothelial-to-mesenchymal transition induced by TGF-β1 in
transplant kidney interstitial fibrosis. J Cell Mol Med.
21:2359–2369. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang W, Li X, Qi S, Li X, Zhou K, Qing S,
Zhang Y and Gao MQ: lncRNA H19 is involved in TGF-β1-induced
epithelial to mesenchymal transition in bovine epithelial cells
through PI3K/AKT signaling pathway. PeerJ. 5:e39502017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu Y, Wan J, Jiang D and Wu X: BMP-7
counteracts TGF-beta1-induced epithelial-to-mesenchymal transition
in human renal proximal tubular epithelial cells. J Nephrol.
22:403–410. 2009.PubMed/NCBI
|
|
16
|
Manson SR, Austin PF, Guo Q and Moore KH:
BMP-7 signaling and its critical roles in kidney development, the
responses to renal injury, and chronic kidney disease. Vitam Horm.
99:91–144. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Beerepoot LV, Mehra N, Linschoten F, Jorna
AS, Lisman T, Verheul HM and Voest EE: Circulating endothelial
cells in cancer patients do not express tissue factor. Cancer Lett.
213:241–248. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang H, Liu Y, Yan L, Du W, Zhang X,
Zhang M, Chen H, Zhang Y, Zhou J, Sun H and Zhu D: Bone
morphogenetic protein-7 inhibits endothelial-mesenchymal transition
in pulmonary artery endothelial cell under hypoxia. J Cell Physiol.
233:4077–4090. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gendron N and Smadja DM: Circulating
endothelial cells: A new biomarker of endothelial dysfunction in
hematological diseases. Ann Biol Clin (Paris). 74:395–404.
2016.PubMed/NCBI
|
|
21
|
Erdbruegger U, Dhaygude A, Haubitz M and
Woywodt A: Circulating endothelial cells: Markers and mediators of
vascular damage. Curr Stem Cell Res Ther. 5:294–302. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sampson UK, Engelgau MM, Peprah EK and
Mensah GA: Endothelial dysfunction: A unifying hypothesis for the
burden of cardiovascular diseases in sub-Saharan Africa. Cardiovasc
J Afr. 26 (2 Suppl 1):S56–S60. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Blann AD, Seigneur M, Steiner M, Boisseau
MR and McCollum CN: Circulating endothelial cell markers in
peripheral vascular disease: RelationshiPto the location and extent
of atherosclerotic disease. Eur J Clin Invest. 27:916–921. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Martínez-Sales V, Sánchez-Lázaro I, Vila
V, Almenar L, Contreras T and Reganon E: Circulating endothelial
cells in patients with heart failure and left ventricular
dysfunction. Dis Markers. 31:75–82. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang C, Li H, Fu P, Zhang S and Xiu R:
Serum C-reactive protein and circulating endothelial cells in
patients with acute myocardial infarction. Clin Hemorheol
Microcirc. 32:287–296. 2005.PubMed/NCBI
|
|
26
|
Torres C, Matos R, Morais S, Campos M and
Lima M: Soluble endothelial cell molecules and circulating
endothelial cells in patients with venous thromboembolism. Blood
Coagul Fibrinolysis. 28:589–595. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Woywodt A, Gerdes S, Ahl B, Erdbruegger U,
Haubitz M and Weissenborn K: Circulating endothelial cells and
stroke: Influence of stroke subtypes and changes during the course
of disease. J Stroke Cerebrovasc Dis. 21:452–458. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ilie M, Long E, Hofman V, Selva E,
Bonnetaud C, Boyer J, Vénissac N, Sanfiorenzo C, Ferrua B,
Marquette CH, et al: Clinical value of circulating endothelial
cells and of soluble CD146 levels in patients undergoing surgery
for non-small cell lung cancer. Br J Cancer. 110:1236–1243. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Geng H and Guan J: MiR-18a-5p inhibits
endothelial-mesenchymal transition and cardiac fibrosis through the
Notch2 pathway. Biochem Biophys Res Commun. 491:329–336. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu X, Friehs I, Zhong Hu T, Melnychenko I,
Tampe B, Alnour F, Iascone M, Kalluri R, Zeisberg M, Del Nido PJ
and Zeisberg EM: Endocardial fibroelastosis is caused by aberrant
endothelial to mesenchymal transition. Circ Res. 116:857–866. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ribera J, Pauta M, Melgar-Lesmes P,
Córdoba B, Bosch A, Calvo M, Rodrigo-Torres D, Sancho-Bru P, Mira
A, Jiménez W and Morales-Ruiz M: A small population of liver
endothelial cells undergoes endothelial-to-mesenchymal transition
in response to chronic liver injury. Am J Physiol Gastrointest
Liver Physiol. 313:G492–G504. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang S and Hirschberg R: Bone
morphogenetic protein-7 signals opposing transforming growth factor
beta in mesangial cells. J Biol Chem. 279:23200–23206. 2004.
View Article : Google Scholar : PubMed/NCBI
|
